中成药在防治食管癌中的研究进展  

Progress of Chinese Patent Medicine in the Treatment of Esophageal Cancer

作　　者：柳芳[1] 刘青[2] 贾立群[2] 娄彦妮[2] LIU Fang;LIU Qing;JIA Liqun;LOU Yanni(Dept.of Pharmacy,China-Japan Friendship Hospital,Beijing 100029,China;Dept.of Oncology of Integrated chinese and Western Medicine,China-Japan Friendship Hospital,Beijing 100029,China)

机构地区：[1]中日友好医院药学部,北京100029 [2]中日友好医院中西医结合肿瘤科,北京100029

出　　处：《中国医院用药评价与分析》2023年第10期1277-1280,共4页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：中日友好医院“菁英计划”人才培育工程项目(No.ZRJY2021-TD05)。

摘　　要：食管癌是我国常见恶性肿瘤之一,其预后较差。目前多采用手术、化疗、放疗、免疫治疗以及中医药治疗。中成药作为中医药治疗的重要方法,近年来在食管癌防治中备受关注。因此,本文梳理总结了已获批可用于食管癌的中成药以及其他中成药在防治食管癌方面的研究进展,以期为食管癌治疗中的中成药合理选用和后续中药新药研发提供参考。Esophageal cancer is one of the common malignant tumors in China,and its prognosis is poor.At present,surgery,chemotherapy,radiotherapy,immunotherapy and traditional Chinese medicine are mostly used.As an essential method of traditional Chinese medicine treatment,Chinese patent medicine has attracted much attention in the prevention and treatment of esophageal cancer in recent years.In order to provide reference for the rational use of Chinese patent medicine and subsequent research and development of drug for esophageal cancer,this paper summarizes the research progress and shortcomings of Chinese patent medicine approved for esophageal cancer and other Chinese patent medicine in the prevention and treatment of esophageal cancer.

关 键 词：食管癌 中成药 研究进展 

分 类 号：R932[医药卫生—生药学]